HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dario Neri Selected Research

Fibrosarcoma

1/2017Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen.
6/2014The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivo.
4/2006Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dario Neri Research Topics

Disease

195Neoplasms (Cancer)
12/2022 - 03/2002
18Melanoma (Melanoma, Malignant)
11/2020 - 04/2011
17Neoplasm Metastasis (Metastasis)
01/2021 - 05/2007
17Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 04/2010
14Inflammation (Inflammations)
01/2021 - 04/2007
13Teratocarcinoma
09/2018 - 07/2002
11Necrosis
09/2021 - 01/2007
11Arthritis (Polyarthritis)
01/2021 - 01/2007
9Carcinoma (Carcinomatosis)
12/2020 - 04/2006
9Lymphoma (Lymphomas)
01/2018 - 03/2009
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 09/2013
7Leukemia
01/2021 - 09/2013
6Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 12/2008
6Rheumatoid Arthritis
01/2019 - 03/2002
6Hematologic Neoplasms (Hematological Malignancy)
11/2017 - 06/2008
6Kidney Neoplasms (Kidney Cancer)
01/2017 - 11/2006
5Sarcoma (Soft Tissue Sarcoma)
01/2021 - 01/2017
4Hypoxia (Hypoxemia)
10/2020 - 06/2004
4Colitis
10/2019 - 08/2015
4Glioma (Gliomas)
06/2018 - 07/2006
4Fibrosis (Cirrhosis)
12/2016 - 02/2010
4Experimental Arthritis
01/2016 - 01/2007
4Breast Neoplasms (Breast Cancer)
01/2015 - 04/2007
4Atherosclerotic Plaque (Atheroma)
02/2011 - 12/2004
3Fibrosarcoma
01/2017 - 04/2006
3Disease Progression
08/2015 - 06/2013

Drug/Important Bio-Agent (IBA)

99Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2002
80Fibronectins (Fibronectin)IBA
03/2022 - 03/2002
67CytokinesIBA
03/2022 - 03/2002
52AntigensIBA
11/2021 - 07/2003
48AntibodiesIBA
01/2021 - 03/2002
34Interleukin-2 (IL2)IBA
01/2021 - 03/2002
31Monoclonal AntibodiesIBA
11/2020 - 12/2002
28Pharmaceutical PreparationsIBA
01/2022 - 12/2002
26Immunoglobulin FragmentsIBA
01/2021 - 07/2002
26F8 monoclonal antibodyIBA
01/2021 - 06/2008
22TenascinIBA
01/2020 - 06/2005
21LigandsIBA
11/2021 - 12/2002
21Biological ProductsIBA
01/2021 - 08/2005
19Protein Isoforms (Isoforms)IBA
01/2020 - 03/2002
17Immunoconjugates (Immunoconjugate)IBA
01/2022 - 11/2002
15Peptides (Polypeptides)IBA
11/2021 - 07/2002
14Carbonic Anhydrase IXIBA
06/2021 - 08/2009
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021 - 06/2003
12Interleukin-12 (IL 12)IBA
01/2021 - 06/2003
11Immunoglobulin G (IgG)IBA
01/2020 - 11/2002
8Acetazolamide (Diamox)FDA LinkGeneric
10/2020 - 08/2009
8Interleukin-4 (Interleukin 4)IBA
01/2018 - 01/2014
8Coloring Agents (Dyes)IBA
04/2014 - 06/2005
7Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2007
6Radioisotopes (Radionuclides)IBA
01/2022 - 01/2010
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 10/2008
6CollagenIBA
01/2021 - 01/2007
6Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
6Indicators and Reagents (Reagents)IBA
11/2020 - 08/2005
6Dacarbazine (DIC)FDA LinkGeneric
01/2020 - 12/2011
6Interleukin-10 (Interleukin 10)IBA
01/2019 - 01/2007
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018 - 11/2002
6Cytotoxins (Cytolysins)IBA
01/2017 - 04/2006
5monomethyl auristatin EIBA
01/2021 - 01/2017
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2019 - 08/2014
4Fluorescein (Funduscein)FDA LinkGeneric
11/2021 - 02/2013
4Interleukin-15 (Interleukin 15)IBA
01/2021 - 05/2007
4Messenger RNA (mRNA)IBA
10/2020 - 06/2004
4Glycoproteins (Glycoprotein)IBA
01/2020 - 05/2006
4Melphalan (Alkeran)FDA LinkGeneric
01/2020 - 05/2004
4Dextrans (Dextran)FDA Link
10/2019 - 08/2015
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2019 - 08/2015
4Sunitinib (Sutent)FDA Link
06/2018 - 12/2010
4DisulfidesIBA
01/2017 - 04/2014
4DipeptidesIBA
01/2017 - 12/2016
4Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 01/2014
4Paclitaxel (Taxol)FDA LinkGeneric
09/2014 - 04/2012
4oncofetal fibronectinIBA
02/2012 - 04/2007
4Biotin (Vitamin H)FDA Link
04/2011 - 04/2007
3Extracellular Matrix ProteinsIBA
01/2022 - 05/2003
3Chimeric Antigen ReceptorsIBA
11/2021 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
06/2021 - 04/2011
3EnzymesIBA
01/2021 - 01/2017
3Therapeutic UsesIBA
01/2021 - 06/2003
3EpitopesIBA
10/2020 - 03/2009
3Vascular Endothelial Growth Factor CIBA
10/2019 - 08/2010
3AcidsIBA
02/2019 - 01/2016
3Sorafenib (BAY 43-9006)FDA Link
01/2017 - 12/2010
3Bispecific AntibodiesIBA
03/2016 - 11/2012
3Maytansine (Maitansine)IBA
11/2015 - 04/2014
3ProteomeIBA
03/2014 - 07/2009
3AlbuminsIBA
08/2011 - 08/2009
3EstersIBA
07/2010 - 04/2007
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 04/2007
2A-Form DNA (A-DNA)IBA
11/2021 - 06/2021
2placental alkaline phosphataseIBA
11/2021 - 01/2014
2Interleukin-9 (Interleukin 9)IBA
03/2021 - 01/2021

Therapy/Procedure

85Therapeutics
12/2022 - 03/2002
14Immunotherapy
01/2021 - 09/2014
12Drug Therapy (Chemotherapy)
01/2021 - 04/2006
10Intravenous Injections
03/2022 - 07/2002
9Intravenous Administration
01/2021 - 01/2014
7Radioimmunotherapy
05/2014 - 07/2006
3Heart Transplantation (Grafting, Heart)
10/2014 - 01/2011